Entera Bio Ltd.
ENTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001638097
No open-market purchases or sales by Entera Bio Ltd. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Entera Bio Ltd. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +4 vs. Q4 2025
- Shares held
- 7.87M
- −1.47M (−15.7%) vs. Q4 2025
- Total value
- $8.68M
- −$9.45M (−52.1%) vs. Q4 2025
- New holders
- 8
- 5 more added
- Sold out
- 4
- 7 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $19.0M |
| Q1 2026 | 26 | $8.68M |
| Q4 2025 | 22 | $18.1M |
| Q3 2025 | 22 | $17.7M |
| Q2 2025 | 19 | $19.4M |
| Q1 2025 | 18 | $17.4M |
| Q4 2024 | 14 | $15.9M |
| Q3 2024 | 17 | $10.1M |
| Q2 2024 | 15 | $9.75M |
| Q1 2024 | 15 | $7.11M |
| Q4 2023 | 10 | $2.44M |
| Q3 2023 | 12 | $1.87M |
| Q2 2023 | 12 | $2.17M |
| Q1 2023 | 9 | $3.28M |
| Q4 2022 | 12 | $415.9K |
| Q3 2022 | 9 | $4.85M |
| Q2 2022 | 10 | $6.54M |
| Q1 2022 | 12 | $14.2M |
| Q4 2021 | 12 | $15.9M |
| Q3 2021 | 14 | $26.7M |
| Q2 2021 | 14 | $30.6M |
| Q1 2021 | 8 | $7.57M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Entera Bio Ltd.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 5,881,879 | $6.47M | 3.59% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 473,442 | $525.5K | 0.00% | +365,441+338.4% | Added |
| Parkman Healthcare Partners LLC | 288,670 | $320.4K | 0.03% | +13,597+4.9% | Added |
| Citadel Advisors LLC | 245,577 | $272.6K | 0.00% | +205,347+510.4% | Added |
| Seven Fleet Capital Management LP | 205,542 | $228.2K | 0.07% | +70,224+51.9% | Added |
| Marshall Wace, LLP | 195,780 | $217.3K | 0.00% | −431,550−68.8% | Reduced |
| Northern Trust Corp | 146,854 | $163.0K | 0.00% | −1,814−1.2% | Reduced |
| XTX Topco Ltd | 131,622 | $146.1K | 0.00% | +131,622 | New |
| Schonfeld Strategic Advisors LLC | 55,223 | $61.3K | 0.00% | −541,362−90.7% | Reduced |
| Signature Estate & Investment Advisors LLC | 47,328 | $52.5K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 36,830 | $40.9K | 0.00% | −6,310−14.6% | Reduced |
| Jane Street Group, LLC | 32,915 | $36.5K | 0.00% | −41,149−55.6% | Reduced |
| Diadema Partners LP | 23,260 | $25.8K | 0.01% | +23,260 | New |
| Geode Capital Management, LLC | 21,136 | $23.5K | 0.00% | 00.0% | Unchanged |
| Gem Investment Advisors, LLC | 19,135 | $21.2K | 0.02% | 00.0% | Unchanged |
| HRT Financial LP | 15,492 | $17.0K | 0.00% | +15,492 | New |
| Point72 Asset Management, L.P. | 12,382 | $13.7K | 0.00% | −1,181,271−99.0% | Reduced |
| Bank of America Corp | 12,000 | $13.3K | 0.00% | −3,000−20.0% | Reduced |
| The PNC Financial Services Group, Inc. | 10,000 | $11.1K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 7,150 | $7.15K | 0.00% | +7,150 | New |
| Persistent Asset Partners Ltd | 5,881 | $6.53K | 0.00% | +5,881 | New |
| UBS Group AG | 3,212 | $3.56K | 0.00% | +3,195+18,794.1% | Added |
| Morgan Stanley | 400 | $444 | 0.00% | +400 | New |
| Group One Trading, L.P. | 51 | $57 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 20 | $22 | 0.00% | +20 | New |
| SBI Securities Co., Ltd. | 2 | $2 | 0.00% | +2 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −64,910−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −17,142−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,327−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,890−100.0% | Sold out |